Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Parent Training for Feeding Problems in Children With Autism Spectrum Disorder: Initial Randomized Trial.

Johnson CR, Brown K, Hyman SL, Brooks MM, Aponte C, Levato L, Schmidt B, Evans V, Huo Z, Bendixen R, Eng H, Sax T, Smith T.

J Pediatr Psychol. 2018 Aug 7. doi: 10.1093/jpepsy/jsy063. [Epub ahead of print]

PMID:
30101320
2.

A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism.

Arnold LE, Ober N, Aman MG, Handen B, Smith T, Pan X, Hyman SL, Hollway J, Lecavalier L, Page K, Rice R Jr.

J Child Adolesc Psychopharmacol. 2018 Jun;28(5):322-330. doi: 10.1089/cap.2017.0134. Epub 2018 Apr 25.

PMID:
29694241
3.

Adverse Events of Atomoxetine in a Double-Blind Placebo-Controlled Study in Children with Autism.

Tumuluru RV, Corbett-Dick P, Aman MG, Smith T, Arnold LE, Pan X, Buchan-Page KA, Brown NV, Ryan MM, Hyman SL, Hellings J, Williams C, Hollway JA, Lecavalier L, Rice RR Jr, McAuliffe-Bellin S, Handen BL.

J Child Adolesc Psychopharmacol. 2017 Oct;27(8):708-714. doi: 10.1089/cap.2016.0187. Epub 2017 May 16.

PMID:
28509573
4.

Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study.

Smith T, Aman MG, Arnold LE, Silverman LB, Lecavalier L, Hollway J, Tumuluru R, Hyman SL, Buchan-Page KA, Hellings J, Rice RR Jr, Brown NV, Pan X, Handen BL.

J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):868-876.e2. doi: 10.1016/j.jaac.2016.06.015. Epub 2016 Aug 2.

5.

Developmental Screening of Refugees: A Qualitative Study.

Kroening AL, Moore JA, Welch TR, Halterman JS, Hyman SL.

Pediatrics. 2016 Sep;138(3). pii: e20160234. doi: 10.1542/peds.2016-0234. Epub 2016 Aug 15.

6.

The Pediatric Sleep Clinical Global Impressions Scale-A New Tool to Measure Pediatric Insomnia in Autism Spectrum Disorders.

Malow BA, Connolly HV, Weiss SK, Halbower A, Goldman S, Hyman SL, Katz T, Madduri N, Shui A, Macklin E, Reynolds AM.

J Dev Behav Pediatr. 2016 Jun;37(5):370-6. doi: 10.1097/DBP.0000000000000307.

PMID:
27244298
7.

Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Handen BL, Aman MG, Arnold LE, Hyman SL, Tumuluru RV, Lecavalier L, Corbett-Dick P, Pan X, Hollway JA, Buchan-Page KA, Silverman LB, Brown NV, Rice RR Jr, Hellings J, Mruzek DW, McAuliffe-Bellin S, Hurt EA, Ryan MM, Levato L, Smith T.

J Am Acad Child Adolesc Psychiatry. 2015 Nov;54(11):905-15. doi: 10.1016/j.jaac.2015.08.013. Epub 2015 Sep 3.

8.

The Gluten-Free/Casein-Free Diet: A Double-Blind Challenge Trial in Children with Autism.

Hyman SL, Stewart PA, Foley J, Cain U, Peck R, Morris DD, Wang H, Smith T.

J Autism Dev Disord. 2016 Jan;46(1):205-220. doi: 10.1007/s10803-015-2564-9.

PMID:
26343026
9.

Dietary Supplementation in Children with Autism Spectrum Disorders: Common, Insufficient, and Excessive.

Stewart PA, Hyman SL, Schmidt BL, Macklin EA, Reynolds A, Johnson CR, James SJ, Manning-Courtney P.

J Acad Nutr Diet. 2015 Aug;115(8):1237-48. doi: 10.1016/j.jand.2015.03.026. Epub 2015 Jun 4.

PMID:
26052041
10.

Overweight and Obesity in a Sample of Children With Autism Spectrum Disorder.

de Vinck-Baroody O, Shui A, Macklin EA, Hyman SL, Leventhal JM, Weitzman C.

Acad Pediatr. 2015 Jul-Aug;15(4):396-404. doi: 10.1016/j.acap.2015.03.008. Epub 2015 Apr 30.

PMID:
25937610
11.

Complementary and alternative medicine treatments for children with autism spectrum disorders.

Levy SE, Hyman SL.

Child Adolesc Psychiatr Clin N Am. 2015 Jan;24(1):117-43. doi: 10.1016/j.chc.2014.09.004. Epub 2014 Oct 3. Review.

PMID:
25455579
12.

A review of atomoxetine effects in young people with developmental disabilities.

Aman MG, Smith T, Arnold LE, Corbett-Dick P, Tumuluru R, Hollway JA, Hyman SL, Mendoza-Burcham M, Pan X, Mruzek DW, Lecavalier L, Levato L, Silverman LB, Handen B.

Res Dev Disabil. 2014 Jun;35(6):1412-24. doi: 10.1016/j.ridd.2014.03.006. Epub 2014 Apr 16. Review.

13.

Relationships between feeding problems, behavioral characteristics and nutritional quality in children with ASD.

Johnson CR, Turner K, Stewart PA, Schmidt B, Shui A, Macklin E, Reynolds A, James J, Johnson SL, Manning Courtney P, Hyman SL.

J Autism Dev Disord. 2014 Sep;44(9):2175-84. doi: 10.1007/s10803-014-2095-9.

PMID:
24664635
14.

A community cross-sectional survey of medical problems in 440 children with Down syndrome in New York State.

Roizen NJ, Magyar CI, Kuschner ES, Sulkes SB, Druschel C, van Wijngaarden E, Rodgers L, Diehl A, Lowry R, Hyman SL.

J Pediatr. 2014 Apr;164(4):871-5. doi: 10.1016/j.jpeds.2013.11.032. Epub 2013 Dec 22.

PMID:
24367984
15.

Complementary and alternative medicine use in a large pediatric autism sample.

Perrin JM, Coury DL, Hyman SL, Cole L, Reynolds AM, Clemons T.

Pediatrics. 2012 Nov;130 Suppl 2:S77-82. doi: 10.1542/peds.2012-0900E.

PMID:
23118257
16.

Iron status in children with autism spectrum disorder.

Reynolds A, Krebs NF, Stewart PA, Austin H, Johnson SL, Withrow N, Molloy C, James SJ, Johnson C, Clemons T, Schmidt B, Hyman SL.

Pediatrics. 2012 Nov;130 Suppl 2:S154-9. doi: 10.1542/peds.2012-0900M.

17.

Nutrient intake from food in children with autism.

Hyman SL, Stewart PA, Schmidt B, Cain U, Lemcke N, Foley JT, Peck R, Clemons T, Reynolds A, Johnson C, Handen B, James SJ, Courtney PM, Molloy C, Ng PK.

Pediatrics. 2012 Nov;130 Suppl 2:S145-53. doi: 10.1542/peds.2012-0900L.

18.

Autism and pediatric practice: toward a medical home.

Hyman SL, Johnson JK.

J Autism Dev Disord. 2012 Jun;42(6):1156-64. doi: 10.1007/s10803-012-1474-3. Review.

PMID:
22411200
19.

Asking the right questions: meaningful outcome measures for neurodevelopmental disorders.

Hyman SL.

Neurology. 2011 Nov 15;77(20):1781-2. doi: 10.1212/WNL.0b013e3182377fbb. Epub 2011 Oct 19. No abstract available.

PMID:
22013186
20.

Should all children be screened for autism spectrum disorders? Yes: merging science, policy, and practice.

Lipkin PH, Hyman SL.

Am Fam Physician. 2011 Aug 15;84(4):361-7. No abstract available.

21.

Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior.

Payne JM, Hyman SL, Shores EA, North KN.

Child Neuropsychol. 2011;17(4):313-29. doi: 10.1080/09297049.2010.542746.

PMID:
21347908
22.

Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report.

Buie T, Campbell DB, Fuchs GJ 3rd, Furuta GT, Levy J, Vandewater J, Whitaker AH, Atkins D, Bauman ML, Beaudet AL, Carr EG, Gershon MD, Hyman SL, Jirapinyo P, Jyonouchi H, Kooros K, Kushak R, Levitt P, Levy SE, Lewis JD, Murray KF, Natowicz MR, Sabra A, Wershil BK, Weston SC, Zeltzer L, Winter H.

Pediatrics. 2010 Jan;125 Suppl 1:S1-18. doi: 10.1542/peds.2009-1878C.

PMID:
20048083
23.

Animal models of autism spectrum disorders: information for neurotoxicologists.

Halladay AK, Amaral D, Aschner M, Bolivar VJ, Bowman A, DiCicco-Bloom E, Hyman SL, Keller F, Lein P, Pessah I, Restifo L, Threadgill DW.

Neurotoxicology. 2009 Sep;30(5):811-21. doi: 10.1016/j.neuro.2009.07.002. Epub 2009 Jul 9.

24.

Complementary and alternative medicine treatments for children with autism spectrum disorders.

Levy SE, Hyman SL.

Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):803-20, ix. doi: 10.1016/j.chc.2008.06.004. Review.

25.

A replication of the Autism Diagnostic Observation Schedule (ADOS) revised algorithms.

Gotham K, Risi S, Dawson G, Tager-Flusberg H, Joseph R, Carter A, Hepburn S, McMahon W, Rodier P, Hyman SL, Sigman M, Rogers S, Landa R, Spence MA, Osann K, Flodman P, Volkmar F, Hollander E, Buxbaum J, Pickles A, Lord C.

J Am Acad Child Adolesc Psychiatry. 2008 Jun;47(6):642-51. doi: 10.1097/CHI.0b013e31816bffb7.

26.

Heterogeneous association between engrailed-2 and autism in the CPEA network.

Brune CW, Korvatska E, Allen-Brady K, Cook EH Jr, Dawson G, Devlin B, Estes A, Hennelly M, Hyman SL, McMahon WM, Munson J, Rodier PM, Schellenberg GD, Stodgell CJ, Coon H.

Am J Med Genet B Neuropsychiatr Genet. 2008 Mar 5;147B(2):187-93.

PMID:
17948868
27.

Olfaction and taste processing in autism.

Bennetto L, Kuschner ES, Hyman SL.

Biol Psychiatry. 2007 Nov 1;62(9):1015-21. Epub 2007 Jun 18.

28.

T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.

Hyman SL, Gill DS, Shores EA, Steinberg A, North KN.

J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1088-91. Epub 2007 Feb 13.

29.

Identifying children with autism early?

Gupta VB, Hyman SL, Johnson CP, Bryant J, Byers B, Kallen R, Levy SE, Myers SM, Rosenblatt AI, Yeargin-Allsopp M.

Pediatrics. 2007 Jan;119(1):152-3. No abstract available. Erratum in: Pediatrics. 2007 Apr;119(4):867.

PMID:
17200280
30.
31.

Age-related findings on MRI in neurofibromatosis type 1.

Gill DS, Hyman SL, Steinberg A, North KN.

Pediatr Radiol. 2006 Oct;36(10):1048-56. Epub 2006 Aug 16.

PMID:
16912896
32.

Is there a 'regressive phenotype' of Autism Spectrum Disorder associated with the measles-mumps-rubella vaccine? A CPEA Study.

Richler J, Luyster R, Risi S, Hsu WL, Dawson G, Bernier R, Dunn M, Hepburn S, Hyman SL, McMahon WM, Goudie-Nice J, Minshew N, Rogers S, Sigman M, Spence MA, Goldberg WA, Tager-Flusberg H, Volkmar FR, Lord C.

J Autism Dev Disord. 2006 Apr;36(3):299-316.

PMID:
16729252
33.

Familial autoimmune thyroid disease as a risk factor for regression in children with Autism Spectrum Disorder: a CPEA Study.

Molloy CA, Morrow AL, Meinzen-Derr J, Dawson G, Bernier R, Dunn M, Hyman SL, McMahon WM, Goudie-Nice J, Hepburn S, Minshew N, Rogers S, Sigman M, Spence MA, Tager-Flusberg H, Volkmar FR, Lord C.

J Autism Dev Disord. 2006 Apr;36(3):317-24.

PMID:
16598435
34.

The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.

Hyman SL, Shores A, North KN.

Neurology. 2005 Oct 11;65(7):1037-44.

PMID:
16217056
35.

Novel treatments for autistic spectrum disorders.

Levy SE, Hyman SL.

Ment Retard Dev Disabil Res Rev. 2005;11(2):131-42. Review.

PMID:
15977319
36.

Introduction: novel therapies in developmental disabilities--hope, reason, and evidence.

Hyman SL, Levy SE.

Ment Retard Dev Disabil Res Rev. 2005;11(2):107-9.

PMID:
15977317
37.

Early regression in social communication in autism spectrum disorders: a CPEA Study.

Luyster R, Richler J, Risi S, Hsu WL, Dawson G, Bernier R, Dunn M, Hepburn S, Hyman SL, McMahon WM, Goudie-Nice J, Minshew N, Rogers S, Sigman M, Spence MA, Goldberg WA, Tager-Flusberg H, Volkmar FR, Lord C.

Dev Neuropsychol. 2005;27(3):311-36.

PMID:
15843100
38.

The use of two language tests to identify pragmatic language problems in children with autism spectrum disorders.

Young EC, Diehl JJ, Morris D, Hyman SL, Bennetto L.

Lang Speech Hear Serv Sch. 2005 Jan;36(1):62-72.

PMID:
15801508
39.

Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism.

Conciatori M, Stodgell CJ, Hyman SL, O'Bara M, Militerni R, Bravaccio C, Trillo S, Montecchi F, Schneider C, Melmed R, Elia M, Crawford L, Spence SJ, Muscarella L, Guarnieri V, D'Agruma L, Quattrone A, Zelante L, Rabinowitz D, Pascucci T, Puglisi-Allegra S, Reichelt KL, Rodier PM, Persico AM.

Biol Psychiatry. 2004 Feb 15;55(4):413-9.

PMID:
14960295
40.
41.

Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies.

Arnold GL, Hyman SL, Mooney RA, Kirby RS.

J Autism Dev Disord. 2003 Aug;33(4):449-54.

PMID:
12959424
42.

Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.

Hyman SL, Gill DS, Shores EA, Steinberg A, Joy P, Gibikote SV, North KN.

Neurology. 2003 Apr 8;60(7):1139-45.

PMID:
12682321
43.

MMR--Separate administration-has it been done?

Leitch R, Halsey N, Hyman SL.

Pediatrics. 2002 Jan;109(1):172. No abstract available.

PMID:
11773568
44.

Pervasive developmental disorders in young children.

Hyman SL, Rodier PM, Davidson P.

JAMA. 2001 Jun 27;285(24):3141-2. No abstract available.

PMID:
11427145
46.

Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders.

Ingram JL, Stodgell CJ, Hyman SL, Figlewicz DA, Weitkamp LR, Rodier PM.

Teratology. 2000 Dec;62(6):393-405.

PMID:
11091361
47.

Neurodevelopmental outcomes in children surviving d-transposition of the great arteries.

Ellerbeck KA, Smith ML, Holden EW, McMenamin SC, Badawi MA, Brenner JI, Kan JS, Hyman SL.

J Dev Behav Pediatr. 1998 Oct;19(5):335-41.

PMID:
9809263
48.

The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency.

Batshaw ML, Yudkoff M, McLaughlin BA, Gorry E, Anegawa NJ, Smith IA, Hyman SL, Robinson MB.

Gene Ther. 1995 Dec;2(10):743-9.

PMID:
8750014
49.

The CAT/CLAMS assessment for early intervention services. Clinical Adaptive Test/Clinical Linguistic and Auditory Milestone Scale.

Rossman MJ, Hyman SL, Rorabaugh ML, Berlin LE, Allen MC, Modlin JF.

Clin Pediatr (Phila). 1994 Jul;33(7):404-9.

PMID:
7525137
50.

Identifying children who need early intervention services.

Wachtel RC, Hyman SL, Compart PJ, Pelham T.

J Pediatr. 1994 Feb;124(2):330-1. No abstract available.

PMID:
7507988

Supplemental Content

Loading ...
Support Center